Comparison of the osteopontin gene expression in gingival tissue related to chronic and acute periodontitis mRNA expression of osteopontin in gingival tissue of the chronic and acute periodontitis
- 1Department of Immunology, Shahidbeheshti University, Tehran, Iran
- 2Department of Biology, Payamenoor University, Tehran, Iran
- 3Department of Immunology, Shahidbeheshti University, Tehran, Iran
- 4Department of Immunology, Shahidbeheshti University, Tehran, Iran and Department of Biology, Payamenoor University, Tehran, Iran
- 5Department of Immunology, Shahidbeheshti University, Tehran, Iran
Res. J. Recent Sci., Volume 7, Issue (10), Pages 1-5, October,2 (2018)
Bacterial infection of periodontal tissue refers to periodontal disease which can lead to bone resorption and tooth loss in severe cases. During the disease procedure, both innate and adaptive immune responses involve that trigger inflammation. Osteopontin (OPN) is an extracellular glycosylated phosphoprotein which increases in inflammation status such as periodontitis. Correlation of the OPN expression and severity of periodontal tissue infection does not investigated yet. Therefore this study assessed OPN expression level in chronic and acute periodontitis to introducing a new correlation between them. For this purpose, gingival tissue samples were collected from 20 patients with chronic periodontitis and 10 persons without obvious sign of periodontitis. Total RNA related to each tissue sample was extracted after homogenizing. The expression of OPNgen (amount of corresponding mRAN) was evaluated by real-time PCR method. Expression of the OPNgene decreased in both types of examined periodontitis and reduced more significantly in acute cases (P<0.05). Statistical analysis revealed presence of significant correlation between negative fold change of gene expression and severity of infectious in periodontal tissue (P<0.05). Results suggest OPN has a possible important role in protection against periodontopathic bacteria and bone lesion, but disease progression accompanied by reduced expression may be due toOPN producer cell death.
- Lerner U.H. (2004)., New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption., Critical Reviews in Oral Biology & Medicine, 15(2), 64-81.
- Page R.C. and Kornman K.S. (1997)., The pathogenesis of human periodontitis: an introduction., Periodontology 2000, 14(1), 9-11.
- Cochran D.L. (2008)., Inflammation and bone loss in periodontal disease., Journal of periodontology, 79(8S), 1569-1576.
- Ohlrich E.J., Cullinan M.P. and Seymour G.J. (2009)., The immunopathogenesis of periodontal disease., Australian dental journal, 54, S2-S10.
- Demmer R.T. and Papapanou P.N. (2010)., Epidemiologic patterns of chronic and aggressive periodontitis., Periodontology 2000, 53(1), 28-44.
- Tanabe N., Wheal B.D., Kwon J., Chen H.H., Shugg R.P., Sims S.M., Goldberg H.A. and Dixon S.J. (2011)., Osteopontin Signals through Calcium and Nuclear Factor of Activated T Cells (NFAT) in Osteoclasts A novel RGD-Dependent Pathway Promoting Cell Survival., Journal of Biological Chemistry, 286(46), 39871-39881.
- Chang I.C., Chiang T.I., Yeh K.T., Lee H. and Cheng Y.W. (2010)., Increased serum osteopontin is a risk factor for osteoporosis in menopausal women., Osteoporosis international, 21(8), 1401-1409.
- Standal T., Borset M. and Sundan A. (2004)., Role of osteopontin in adhesion, migration, cell survival and bone remodeling., Exp Oncol, 26(3), 179-184.
- Ahn H., Kim J.M., Lee K., Kim H. and Jeong D. (2012)., Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration., Biochemical and biophysical research communications, 418(1), 144-148.
- Huang W., Carlsen B., Rudkin G., Berry M., Ishida K., Yamaguchi D.T. and Miller T.A. (2004)., Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells., Bone, 34(5), 799-808.
- Yumoto K., Ishijima M., Rittling S.R., Tsuji K.T., Suchiya Y., Kon S., Nifuji A., Uede T., Denhardt D.T. and Noda M. (2002)., Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice., Proc. Natl. Acad. Sci. U.S.A., 99(7), 4556-4561.
- Rajkarnikar J., Thomas B.S. and Rao S.K. (2013)., Inter-relationship between rheumatoid arthritis and periodontitis., Kathmandu Univ Med J (KUMJ), 11(41), 22-26.
- Ogrendik M. (2013)., Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens., International journal of general medicine, 6, 383-386.
- Kido J.I., Nakamura T., Asahara Y., Sawa T., Kohri K. and Nagata T. (2001)., Osteopontin in gingival crevicular fluid., Journal of periodontal research, 36(5), 328-333.
- Wiebe C.B. and Putnins E.E. (2000)., The periodontal disease classification system of the American Academy of Periodontology-an update., Journal-canadian dental association, 66(11), 594-597.
- Andrew J. Holloway, Dileepa S. Diyagama, Ken Opeskin, Jenette Creaney, Bruce W.S. Robinson, Richard A. Lake and David D.L. (2006)., A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma using Cells Collected from Pleural Effusions., Bowtell Clin Cancer Res., 12(17).
- UCSC Genome Browser (2017). University of California Santa Cruz, Genomics Institute, http://genome. ucsc.edu/, undefined, undefined
- Sharma C.D. and Pradeep A.R. (2006)., Gingival crevicular fluid osteopontin levels in periodontal health and disease., Journal of period ontology, 77(10), 1674-1680.
- Hans S. and Mali A.M. (2012)., Estimation and comparison of osteopontin levels in plasma in subjects with healthy periodontium and generalized chronic periodontitis and its assessment after scaling and root planing., J Indian Soc Periodontol, 16(3), 354-357.
- Walker C.G., Dangaria S., Ito Y., Luan X. and Diekwisch T.G. (2010)., Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption., Bone, 47(6), 1020-1029.